We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
(+3.9%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.96M |
| 2 |
Merck
MRK
|
+$6.29M |
| 3 |
UnitedHealth
UNH
|
+$5.85M |
| 4 |
Amazon
AMZN
|
+$5.11M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$11.9M |
| 2 |
Cardinal Health
CAH
|
+$9.07M |
| 3 |
AT&T
T
|
+$3.98M |
| 4 |
Medtronic
MDT
|
+$3.36M |
| 5 |
Estee Lauder
EL
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.84% |
| 2 | Healthcare | 14.41% |
| 3 | Technology | 13.82% |
| 4 | Industrials | 11.14% |
| 5 | Energy | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Weyerhaeuser
WY
$13.6B
| $378K | 0.03% |
12,569
| – | – |
2016 Q2
2 quarters
|
|
|
PBCT
202
DELISTED
People's United Financial Inc
PBCT
| $376K | 0.03% |
+19,425
| New | +$343K |
2016 Q4
0 quarters
|
|
203
iShares US Real Estate ETF
IYR
$4.12B
| $375K | 0.03% |
4,873
| – | – |
2016 Q1
3 quarters
|
|
204
SPDR Gold Trust
GLD
$139B
| – | – |
0
| – | – |
2016 Q2
2 quarters
|
|
205
Jack Henry & Associates
JKHY
$10.9B
| $355K | 0.03% |
4,000
| – | – |
2016 Q1
3 quarters
|
|
206
Bank of New York Mellon
BNY
$93.4B
| $354K | 0.02% |
7,484
| – | – |
2013 Q2
14 quarters
|
|
207
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $353K | 0.02% |
10,712
-2,956
| -22% | -$95.7K |
2016 Q1
3 quarters
|
|
208
VanEck Junior Gold Miners ETF
GDXJ
$7.76B
| $351K | 0.02% |
11,121
+80
| +0.7% | +$2.91K |
2016 Q1
3 quarters
|
|
|
CTWS
209
DELISTED
Connecticut Water Service Inc
CTWS
| $347K | 0.02% |
+6,205
| New | +$330K |
2016 Q4
0 quarters
|
|
210
Silicon Laboratories
SLAB
$7.38B
| $335K | 0.02% |
+5,148
| New | +$324K |
2016 Q4
0 quarters
|
|
|
BCR
211
DELISTED
CR Bard Inc.
BCR
| $326K | 0.02% |
1,451
+96
| +7% | +$20.9K |
2015 Q3
5 quarters
|
|
212
Invesco QQQ Trust
QQQ
$488B
| $325K | 0.02% |
2,742
-100
| -4% | -$11.8K |
2014 Q4
8 quarters
|
|
|
EBSB
213
DELISTED
Meridian Bancorp, Inc.
EBSB
| $319K | 0.02% |
16,863
| – | – |
2013 Q3
13 quarters
|
|
214
Northrop Grumman
NOC
$70.4B
| $318K | 0.02% |
1,367
| – | – |
2015 Q2
6 quarters
|
|
215
Abeona Therapeutics
ABEO
$249M
| $317K | 0.02% |
2,617
| – | – |
2015 Q2
6 quarters
|
|
216
WisdomTree
WT
$3.19B
| $302K | 0.02% |
27,128
+844
| +3% | +$8.8K |
2016 Q3
1 quarter
|
|
217
J.M. Smucker
SJM
$13B
| $295K | 0.02% |
2,307
| – | – |
2013 Q2
14 quarters
|
|
218
Corcept Therapeutics
CORT
$12.6B
| $290K | 0.02% |
40,000
| – | – |
2013 Q2
14 quarters
|
|
219
WisdomTree Japan Hedged Equity Fund
DXJ
$2.36B
| $290K | 0.02% |
17,553
-26,217
| -60% | -$410K |
2013 Q3
13 quarters
|
|
220
Toronto Dominion Bank
TD
$192B
| $276K | 0.02% |
+5,589
| New | +$261K |
2016 Q4
0 quarters
|
|
221
Huntington Bancshares
HBAN
$30.5B
| $274K | 0.02% |
20,788
-7,110
| -25% | -$82.9K |
2013 Q2
14 quarters
|
|
222
Omnicom Group
OMC
$21.5B
| $273K | 0.02% |
3,205
| – | – |
2016 Q3
1 quarter
|
|
223
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $272K | 0.02% |
+6,684
| New | +$270K |
2016 Q4
0 quarters
|
|
224
BP
BP
$126B
| $270K | 0.02% |
8,438
-154
| -2% | -$4.63K |
2016 Q1
3 quarters
|
|
225
Scotiabank
BNS
$110B
| $268K | 0.02% |
4,800
+1,000
| +26% | +$54.5K |
2016 Q3
1 quarter
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q4 2016 Portfolio in Review
As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
- Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
- Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
- Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
- Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
- Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
- Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.
Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.